Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

ClinicalTrials.gov ID: NCT00367835

Public ClinicalTrials.gov record NCT00367835. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 3:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Multi-Center, Flexible Dose Study Evaluating the Efficacy and Safety of SPD503 (Guanfacine Hydrochloride) in Children Aged 6-12 With Symptoms of Oppositionality and a Diagnosis of Attention Deficit/Hyperactivity Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess efficacy and safety of SPD503(guanfacine hydrochloride) in subjects with ADHD and oppositional symptoms.

Study identification

NCT ID
NCT00367835
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
217 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
6 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 3, 2006
Primary completion
Jan 3, 2008
Completion
Jan 3, 2008
Last update posted
Jun 13, 2021

2006 – 2008

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
HOPE Research Institute Phoenix Arizona 85050
Valley Clinical Research El Centro California 92243
Peninsula Research Associates Inc Rolling Hills Estates California 90274
Sarkis Clinical Trials Gainesville Florida 32607
University of Florida Gainesville Florida 32610
Amedica Research Institute, Inc Hialeah Florida 33013
CORE Research, Inc Maitland Florida 32751
Miami Research Associates Miami Florida 33143
Clinical Neuroscience Solutions, Inc Orlando Florida 32806
Childrens Developmental Center Winter Park Florida 32792
Capstone Clinical Research Libertyville Illinois 60048
Vince and Associates Clinical Research Overland Park Kansas 66212
Pedia Research Owensboro Kentucky 42301
Four Rivers Clinical Research Paducah Kentucky 42003
University of Nebraska Medical Center Omaha Nebraska 68198
CRI Worldwide, LLC Clementon New Jersey 08021
Mount Sinai School of Medicine New York New York 10029
University of Rochester, School of Medicine and Dentistry Rochester New York 14618
SUNY Upsate Medical University Syracuse New York 13210
Piedmont Neuropsychiatry Charlotte North Carolina 28226
Duke Child & Family Study Center Durham North Carolina 27705
University of Cincinnati Cincinnati Ohio 45267
Discovery and Wellness Center for Children Cleveland Ohio 44106
BHI Inc Moore Oklahoma 73160
IPS Research Company Oklahoma City Oklahoma 73103
Oregon Center for Clinical Investigations, Inc Portland Oregon 97210
Oregon Center for Clinical Investigations, Inc Salem Oregon 97301
CRI Worldwide, LLC Philadelphia Pennsylvania 19149
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Claghorn-Lesem Research Clinic Inc Houston Texas 77008
Red Oak Psychiatry Associates, PA Houston Texas 77090
NeuroScience, Inc Herndon Virginia 20170
Dominion Clinical Research Midlothian Virginia 23112
Eastside Therapeutic Resource Kirkland Washington 98033

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00367835, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 13, 2021 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00367835 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →